Comparing bipolar medicines before or during pregnancy
Working out a change to bipolar medicine before or during pregnancy means comparing what continuing, switching or stopping the particular medicine would mean for the person and baby.
The steps connect its past benefit with pregnancy safety, restrictions, blood tests, feeding and a plan around birth. Some risks are well established; others remain uncertain or depend on timing. A specialist in mental health during pregnancy and after birth is needed to explain those differences and agree any change with the prescriber, the professional responsible for the prescription.1,2
Working out a medication plan for pregnancy holds the broader process of exploring worries, priorities and available support. This page works through the medicine-specific part, including precautions for someone taking valproate who could father a child. A partner, friend or relative can help think it through and remember questions.
1. Establish the timing and the benefit worth keeping
Before pregnancy there is time to compare options and plan a change; a pregnancy already underway needs a prompt review. The starting information is the medicine's name, dose and past benefit, whether pregnancy is being considered or already underway, and the current contraception, meaning the method used to prevent pregnancy. Changing or stopping medicine can bring illness back, so a change needs a plan with the prescriber.1,2
A medicine that has kept severe episodes away has a benefit worth preserving. Illness during pregnancy or soon after birth can affect safety, ordinary life and caring for a baby. The comparison therefore needs earlier episode severity, what happened during previous medicine changes, which alternatives helped and any illness after an earlier birth.1
2. Compare the options for the particular medicine
Each option needs an explanation of expected help, possible effects on the baby, when those effects might occur and how much remains uncertain. Continuing, switching and a planned interruption can have different consequences; some interruptions involve restarting later in pregnancy or after birth. When numbers are available, asking how many babies are affected out of the same-sized group makes the comparison clearer.1,2,3
Someone may put most weight on keeping a treatment that has made them well, while also wanting to explore an alternative because of pregnancy or feeding concerns. A preferred option can be brought into the comparison without leaving an unanswered safety question behind. The broader pregnancy decision process holds published accounts of working through those concerns over repeated discussions.4
The medicine-specific choices
The options below differ because the medicines have different pregnancy advice. Each medicine in a combination needs review too.
| Medicine | Consideration for the discussion |
|---|---|
| Lithium | Lithium can sometimes be continued when the risk of becoming unwell is high and alternatives are unlikely to work. There is a small chance of an effect on the baby's heart development when taken early in pregnancy; the exact size of that risk is uncertain. Continuing, switching or a planned interruption involve different benefits and need specialist review. The amount of lithium in the blood needs closer checks during pregnancy and after birth.1,5 |
| Lamotrigine | The amount of medicine in the blood can fall during pregnancy and rise quickly after birth. Blood tests and a plan for reviewing the dose help keep the treatment matched to these changes.1,6 |
| Carbamazepine | For bipolar treatment, pregnancy planning is a reason to discuss changing it because of birth-defect risk and interactions with other medicines. England's pregnancy guidance advises against starting it when pregnancy is planned or underway.1 |
| Medicines such as quetiapine and olanzapine | These belong to the group called antipsychotics, used to treat high mood and, for some medicines, bipolar depression. Continuing a medicine that is keeping someone well can be appropriate when illness is likely to return without it. The review includes weight and checks for gestational diabetes, high blood sugar that develops during pregnancy. Pregnancy safety information is limited and differs by medicine.1 |
Valproate has a specific United Kingdom restriction. It must not be used during pregnancy to treat bipolar because it can cause birth defects and lasting problems with a child's development. Anyone who could become pregnant while taking it needs the pregnancy prevention programme, including contraception and specialist review. A suspected pregnancy needs urgent contact with the prescriber for a treatment plan. Some National Health Service wording groups bipolar with epilepsy; the exception allowing use when no alternative works is for epilepsy, a condition causing repeated seizures or fits. Valproate holds the full restrictions and review arrangements.7,8,9
3. Include fatherhood precautions when valproate is involved
For someone taking valproate who could father a child, there is an uncertain possible risk of developmental problems in a child conceived during treatment. United Kingdom precautions include condoms together with the partner's effective contraception during treatment and for three months after stopping, and avoiding sperm donation over the same period. The decision about trying for a child therefore includes a specialist discussion before contraception is stopped, comparing whether an alternative treatment is suitable. The valproate page explains the precautions and uncertainty.8,10
4. Check whether the option works with feeding and rest
The medicine option needs to fit feeding wishes, the baby's health and rest after birth. Breastfeeding, formula milk or a combination can be compared before birth. Some people value breastfeeding's closeness; others want shared bottle feeds to protect sleep. Those different priorities have their home in the pregnancy decision process, and need the particular medicine's feeding advice alongside them.2,4
Lithium while breastfeeding needs specialist advice and may involve blood tests for the baby as well as a dose review for the parent after birth. Medicine-specific choices and checks are explained in breastfeeding and bipolar treatment.5
Sleep loss can trigger high mood, while late pregnancy and newborn care can make sleep hard to protect. A realistic plan names who can take over care so the parent can rest, what sleeping arrangements are available after delivery, and what happens if sleep or mood changes. The first weeks after birth deserve particular attention because bipolar illness can begin quickly then. Making a care plan for pregnancy and after birth brings the treatment, practical help and contacts together; postpartum psychosis explains the sudden loss of contact with reality after birth that needs urgent assessment.1,2
5. Resolve the remaining medicine questions
The medication review prompts hold doses, benefit, unwanted effects and earlier treatments. The remaining pregnancy questions can be worked through with the specialist using this record:
| Part of the decision | Questions worth bringing |
|---|---|
| Timing | Is pregnancy being considered, actively planned or already underway? What is the current contraception plan? |
| Previous illness and treatment | Which medicines have kept the person well? What happened during earlier changes or after a previous birth? |
| Options | What would continuing, changing or stopping each medicine mean for this person and the baby? Which effects are known, how common are they, and which are uncertain? |
| Checks and birth | Which blood tests or other checks are needed, who arranges them, and how does the plan change around delivery and afterwards? |
| Feeding and practical help | What feeding options fit the treatment and the person's wishes? Who can help with feeds, rest and everyday tasks? |
| Responsibility and contact | Who brings the advice together? What change needs an earlier review, and whom can the person or a supporter contact? |
Writing the answers down makes the options easier to compare afterwards. A chosen supporter can help remember them. When advice differs between services, asking who will reconcile it gives the decision a next step and someone responsible.1,2,4
6. Record the choice, checks and way to revisit it
The agreed plan records the chosen treatment and reasons, checks, arrangements around delivery, and a contact for questions or earlier review. It names who orders tests, acts on results and brings advice together, with a review date and copies shared with the person and those involved. A new concern or changed preference can reopen the decision.1,3
For example, someone has stayed well on lithium and hopes to become pregnant. They compare continuing it with an alternative, using earlier episode history and the explained risks to the baby. Before settling on continuation, they ask who will arrange closer blood checks and how the plan changes around birth and feeding. An unanswered question about the tests becomes the next specialist discussion. The written agreement records the treatment, checks and a date to review it; a different treatment history could lead to a different choice.1
Related: Working out a medication plan for pregnancy · Bipolar, pregnancy and a new baby · Feeding a baby while taking medicine for bipolar.
Sources
- 1Antenatal and postnatal mental health: clinical management and service guidance NICE
- 2Planning your pregnancy: Information for women with bipolar or previous postpartum psychosis, to read and personalise Pregnancy preparation workbook
- 4Experiences of decision making about psychotropic medication during pregnancy and breastfeeding in women living with severe mental illness: a qualitative study Pregnancy interviews
- 5Pregnancy, breastfeeding and fertility while taking lithium NHS
- 6Lamotrigine – Use in Bipolar Disorder NHS
- 7Valproate medicines (Epilim▼, Depakote▼): contraindicated in women and girls of childbearing potential unless conditions of Pregnancy Prevention Programme are met UK government
- 8Valproate – reproductive risks UK government
- 9Pregnancy, breastfeeding and fertility while taking valproic acid NHS
- 10VALPROATE GUIDE FOR MALE PATIENTS UK medicines guide
Last updated 12 October 2026
